+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fibronectin is unsuitable as a tumor marker in pleural effusion due to malignant pleural mesothelioma



Fibronectin is unsuitable as a tumor marker in pleural effusion due to malignant pleural mesothelioma



Chest 106(2 Suppl. ): 96S




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031444513

Download citation: RISBibTeXText


Related references

Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. European Journal of Radiology 85(9): 1594-1600, 2016

Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer 82(3): 491-498, 2013

Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma. Anticancer Research 30(10): 4343-4346, 2010

Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis. Clinical Cancer Research 9(7): 2605-2612, 2003

Fibronectin is unsuitable as a tumor marker in pleural effusions. Clinical Chemistry 35(1): 166-168, 1989

49P Accuracy of pleural fluid cytology in patients with malignant pleural effusion from non-small-cell lung cancer, pulmonary metastases and pleural mesothelioma. A case-control study. Journal of Thoracic Oncology 11(4 Suppl.): S75-S75, 2016

Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. European Journal of Surgical Oncology 35(5): 546-551, 2009

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (Gmci) for Malignant Pleural Effusion (Mpe) and Malignant Pleural Mesothelioma (Mpm). Journal of Thoracic Oncology 12(11): S2151-S2152, 2017

The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion. Indian Journal of Cancer 51(Suppl. 3): E82-E85, 2014

Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion. Journal of Clinical Laboratory Analysis 33(6): E22901, 2019

Assessment of the value of fibronectin as a tumour marker in malignant pleural mesothelioma. Monaldi Archives for Chest Disease 52(4): 335-338, 1997

Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma. Respiratory Medicine 105(1): 137-142, 2011

Endoscopic diagnosis and management of pleural effusion in malignant pleural mesothelioma. Journal of Thoracic Disease 10(Suppl 2): S269-S275, 2018

Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma. Clinical Chemistry and Laboratory Medicine 49(10): 1721-1726, 2011

Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma. Oncology Letters 3(3): 581-585, 2012